9月22日港股创新药ETF（159567）份额减少800.00万份

Core Insights - The Hong Kong Innovative Drug ETF (159567) increased by 1.50% on September 22, with a trading volume of 1.263 billion yuan [1] - The fund's shares decreased by 8 million, bringing the total shares to 8.162 billion, while the shares increased by 1.985 billion over the last 20 trading days [1] - The latest net asset value of the fund is 7.729 billion yuan [1] - The performance benchmark for the ETF is the National Index of Hong Kong Innovative Drugs, adjusted for valuation exchange rates [1] - The fund is managed by Yinhua Fund Management Co., Ltd., with Ma Jun as the fund manager [1] - Since its inception on January 3, 2024, the fund has returned 89.40%, while the return over the past month is -5.75% [1]